ALung Technologies developed the world’s first commercial artificial lung device—the HemoLung RAS.  By delivering oxygen to the blood and removing carbon dioxide, the HemoLung provides safer and less expensive respiratory support than mechanical ventilation, the current standard of care. ( acquired by Liva Nova)